1 Introduction

The rapid and continuous emergence of vector-borne diseases (VBDs) is at the heart of public health concern worldwide [1,2,3]. Although conventional insecticides have been largely employed, their overuse has led to negative effects on human and environmental health and has contributed to the rise of insecticide resistance [4, 5]. From this derives the urgent need to discover effective, novel, safe, and eco-friendly products, and essential oils (EOs) are raising considerable interest as sources of bioactive compounds employable as insecticides [6]. Commiphora myrrha (T.Nees) Engl. (syn. Commiphora molmol (Engl.) Engl. ex Tschirch), commonly known as myrrh, is a sturdy, gray-barked shrub belonging to the Burseraceae family, largely distributed in South-Arabia and North-East Africa. Its long history of use as a medicinal plant is attributed to its oleo-gum resin [7], consisting of a water-soluble gum, alcohol-soluble resin, and a fluid fraction made up of volatile compounds [8], that are mainly represented by furanosesquiterpenes [9]. Nowadays, the oleo-gum resin of myrrh finds many applications in pharmaceuticals, cosmetics, foods, and herbal products [10], and this is also linked to its relatively low price on the market (11.00–15.00 $/kg for myrrh obtained in Africa) [11]. The oleo-gum resin is traditionally employed to treat several health issues [8] and has been studied for its significant antiseptic, anesthetic, and antitumor properties [12]. Additionally, myrrh is employed as flavoring in alcoholic and non-alcoholic beverages, with a maximum permitted level of 0.025%, as well as in dairy products, frozen, sweet, baked goods, and meat and derivatives [10].

The insecticidal and acaricidal activity of C. myrrha EO has scarcely been investigated, with studies limited to its effects on the food-stored product beetle Sitophilus oryzae (L.) and the two-spotted spider mite Tetranychus urticae Koch [13, 14]. However, no data is currently available regarding the efficacy of the EO on mosquito vectors. This study aimed to evaluate the larvicidal activity of myrrh EO on Culicidae of public health relevance as Aedes albopictus Skuse, Ae. aegypti L., Anopheles gambiae Giles, and An. stephensi Liston. Additionally, a bio-guided fractionation of the EO was performed to verify the involvement of furanosesquiterpenes in its insecticidal action. An untargeted metabolomic analysis was conducted to assess the possible metabolic pathways affected by the treatment. Furthermore, non-target toxicity was assessed on Daphnia magna Straus, and cytotoxicity was examined on human non-tumoral embryonic kidney 293 cells (HEK293).

2 Results and discussion

2.1 GC–MS analysis of the essential oil and its fractions

The C. myrrha EO was chemically characterized through GC–MS analysis, with a total of identified compounds of 96.50% (Table 1). The EO resulted mainly dominated by furanosesquiterpenes (87.37%), followed by sesquiterpene hydrocarbons (8.04%), oxygenated sesquiterpenes (1.06%), and other compounds in minor amounts. Furanoeudesma-1,3-diene was the most abundant furanosesquiterpene (41.40%), followed by curzerene (25.89%), lindestrene (13.09%), and isofuranodiene (2.00%). Among the sesquiterpene hydrocarbons, β-elemene (2.87%) and germacrene B (2.11%) were the major components. The chemical composition of this EO is linear with those reported for EO from Ethiopian plants [15, 16]. Furanoeudesma-1,3-diene was consistently the major compound across all samples, with percentages ranging from 34 to 39% of the total composition, followed by isofuranodiene (20%) [15], and lindestrene (12–14%) [15, 16]. In contrast, the chemical composition differs from that reported by Morteza-Semnani et al. [17], that found curzerene (40%) as the dominant compound. However, the high levels of curzerene in the EO are misleading since, during GC–MS analysis, isofuranodiene is converted into curzerene through the Cope rearrangement [18]. For this reason, the GC–MS quali-/quantitative analysis of isofuranodiene is generally inappropriate.

Table 1 Chemical composition of the essential oil (EO) of Commiphora myrrha

Then, the EO was fractionated into two main fractions, which were subsequently analyzed by GC–MS. Fraction 1, with 94.37% of identified compounds, was primarily characterized by sesquiterpene hydrocarbons, with β-elemene and germacrene B as the main components (29.08 and 15.81%, respectively). δ-Elemene (6.94%), β-selinene (6.33%), α-selinene (6.12%), γ-elemene (5.64%), and germacrene D (4.79%) were also found in minor percentages (Table S2, Supplementary File 1). The GC–MS analysis of fraction 2 confirmed the presence of furanosesquiterpenes contained in the EO, with a total of identified compounds of 99.70%. This fraction was predominantly characterized by furanoeudesma-1,3-diene (44.95%), curzerene (33.90%), and lindestrene (16.67%) (Table S3, Supplementary File 1), with smaller amounts of atractylon and isofuranodiene (1.85 and 1.60%, respectively).

2.2 Purification of furanosesquiterpenes

Fraction 2 (348 mg) was further purified to give 37.7 mg of furanoeudesma-1,3-diene, 13 mg of curzerene, and 8 mg of isofuranodiene. The structures of the furanosesquiterpenes were confirmed by 1H, 13C NMR, MS spectrometry, and IR spectroscopy aligning with published data [25,26,27]. The full characterization of the isolated compounds is reported in Supplementary File 1 along with the NMR spectra for furanoeudesma-1,3-diene (Supplementary File 1, Fig. S2, S3, S4).

2.3 HPLC–DAD quantitative analysis

The main furanosesquiterpenes of C. myrrha EO and fraction 2, namely furanoeudesma-1,3-diene, isofuranodiene, and curzerene, were quantified through HPLC–DAD analysis (Fig. 1) to avoid the thermal degradation of isofuranodiene and to have a reliable quantification of the compounds. In detail, furanoeudesma-1,3-diene was confirmed as the predominant furanosesquiterpene (68.42 g/100 g EO), followed by curzerene (18.03 g/100 g EO), and isofuranodiene (7.40 g/100 g EO). Similar levels were also found in fraction 2, as reported in Table S4, Supplementary File 1.

Fig. 1
figure 1

HPLC–DAD chromatogram of Commiphora myrrha essential oil (EO)

These results are consistent with those obtained from the GC–MS quali-/quantitative analysis, where furanoeudesma-1,3-diene was identified as the principal furanosesquiterpene. The presence of curzerene, also confirmed by HPLC–DAD analysis, may be attributed to the extraction protocol applied to C. myrrha oleo-gum resin to obtain the EO, which could have led to the formation of high amounts of curzerene through thermal degradation of isofuranodiene. Further details on the quantification of the furanosesquiterpenes are provided in Supplementary File 1 (Table S4).

2.4 Mosquito larvicidal activity

This study aimed to assess the larvicidal potential of C. myrrha EO on four mosquito species of significant health impact and to identify the class of compounds primarily responsible for the activity. Both C. myrrha EO and its furanosesquiterpene fraction proved to be highly effective against all the mosquito species tested (LC50 from 4.42 to 16.81 and from 3.72 to 5.04 μg/mL, respectively) (Table 2).

Table 2 Larvicidal activity of the Commiphora mhyrra essential oil (EO), and its derived products against Anopheles and Aedes mosquito species

While mortality rates increased with higher concentrations of both the furanosesquiterpene fraction and EO, the former proved to be more effective against all the tested species. However, the furanosesquiterpene fraction achieved a higher mortality rate at lower doses if compared with the EO (Fig. S5, Supplementary File 1), and LC10, LC30, LC50, and LC90 values were reached with lower doses (Fig. S6, Supplementary File 1).

Regarding pure compounds, they were tested on Ae. aegypti since this species showed the highest sensitivity to the EO treatment among the four target vectors. Furanoeudesma-1,3-diene resulted to be the most effective (LC50 3.28 µg/mL), followed by isofuranodiene (LC50 5.58 µg/mL), and curzerene (LC50 7.44 µg/mL) (Table 2, Fig. 2a) (GLMM post-hoc with Bonferroni correction—Furanoeudesma-1,3-diene vs. Isofuranodiene: OR = 22.983, SE = 8.058, z = 8.941, p < 0.0001; Furanoeudesma-1,3-diene vs. EO: OR = 14.484, SE = 5.147, z = 7.478, p < 0.0001; Furanosesquiterpenes fraction vs. Furanoeudesma-1,3-diene: OR = 0.129, SE = 0.046, z = -5.655, p < 0.0001; Curzerene vs. Furanoeudesma-1,3-diene: OR = 0.023, SE = 0.008, z = -10.679, p < 0.0001). Concerning the mortality rates of all the tested products, furanoeudesma-1,3-diene reached the highest mortality rate with the lowest doses if compared with the others, and even a slight increase in its concentration led to a significantly faster mortality trend (Fig. 2b).

Fig. 2
figure 2

a Overall species mortality rate of Aedes aegypti treated with the essential oil (EO), the furanosesquiterpene fraction, furanoeudesma-1,3-diene, isofuranodiene, and curzerene, regardless of the tested concentrations. b Mortality trend of Aedes aegypti by increasing the concentration of the essential oil (EO), the furanosesquiterpene fraction, furanoeudesma-1,3-diene, isofuranodiene, and curzerene. Colored dots indicate the total number of tested individuals clustered around 0 when alive or around 1 when dead.

This is the first study that reports the larvicidal activity of C. myrrha EO and demonstrates the key role of furanosesquiterpenes in its efficacy. Furthermore, all the tested products exhibited strong activity against the treated mosquito larvae, with LC50 values below 20 μg/mL.

The extracts derived from species of the genus Commiphora Jacq. have been previously tested on mosquitoes. Indeed, the extract deriving from C. myrrha resin showed an LC50 of 281.83 μg/mL on Ae. aegypti larvae [28], while C. caudata (Wight & Arn.) Engl. extracts exhibited mild toxicity on Ae. aegypti, An. stephensi, and Culex quinquefasciatus Say (LC50 ranging from 94.76 to 112.85 μg/mL) [29]. Comparable results were also obtained for the EO from C. berryi (Arn.) Engl. (LC50 ranging from 122 to 175 μg/mL) [30]. Conversely, extracts from C. swynnertonii Burtt resin displayed lower LC50 values (ranging from 3.95 to 27.04 μg/mL) on An. gambiae, Cx. quinquefasciatus, and Ae. aegypti [31]. The EO from C. erythraea (Ehrenb.) Engl. showed a higher toxicity against Cx. pipiens L., Cx. restuans Theobald, and Ae. aegypti, with LC50 values ranging from 10.05 to 29.83 μg/mL [32]. It is worthy of notice that the above-mentioned extracts from Commiphora species are chemically different from the EO tested in this work, being the latter more concentrated in bioactive furanosesquiterpenes.

Regarding other botanical products, Pavela [33] demonstrated that, although many studies report the mosquito larvicidal activity of EOs, only some of them (i.e., Cinnamomum microphyllum Ridl., C. mollissimum Hook. F., C. rhyncophyllum (Miq.), Callitris glaucophylla Joy Thomps. & L.P. Johnson, Auxemma glazioviana Taub., Blumea densiflora D.C., and Zanthoxylum oxyphyllum Edgew.) displayed LC50 below 10 μg/mL [33]. Indeed, among them, only the EOs from A. glazioviana (LC50 of 3 μg/mL against Ae. aegypti) [34] and C. glaucophylla (LC50 = 0.7 μg/mL against Ae. aegypti) [35] showed an efficacy like that reported in this work. Overall, our results demonstrate that C. myrrha EO is an effective product against mosquito larvae.

2.5 GC–MS-driven untargeted metabolomic analysis

The untargeted metabolomic analysis allowed the extraction of 565 ions, 172 of which were putatively annotated and belonged to different classes of compounds such as amino acids, organic acids, sugars and sugar alcohols, and fatty acids among others (Supplementary File 2, Table S7). Data were first explored by unsupervised PCA (Fig. 3a) built under the first two PCs, which explained 90.4% of the total variance (82% of the PC1 and 8.4% of the PC2). As reported by the PCA loading plots, the PC1 was mainly dominated by compounds such as spermidine, 6-hydroxy nicotinic acid, xanthine, hypoxanthine and asparagine, whereas the PC2 by 3-hydroxy propionic acid, 4-hydroxybutyric acid, glycolic acid, 3-phosphoglycerate and lactic acid (Supplementary File 2, Table S7).

Fig. 3
figure 3

a PCA scores plot between the selected PCs. The explained variances are shown in brackets; b OPLS-DA score plot of all metabolite features; c VIP scores derived from the OPLS-DA model; d Correlation network obtained by DSPC algorithm using metabolites the metabolites discriminating treated from untreated larvae, blue nodes represent metabolites, red lines indicate a positive correlation between metabolites. In contrast, the blue lines indicate a negative correlation. N = 5

The good separation highlighted by PCA allowed further data processing through supervised discriminant multivariate analysis such as OPLS-DA, which is specifically designed to identify variables that contribute to the differentiation between these groups, focusing on the variations that are directly related to group discrimination and enhancing the ability of the model to identify and highlight differences between groups [36].

As reported in Fig. 3b, the validated (Supplementary File 2, Table S7) OPLS-DA model confirmed the separation of the control and treated groups, indicating that their differences were statistically reliable (Fig. 3b). Further, the VIP scores analysis allowed us to identify those compounds that could be considered the main drivers of group separation (Fig. 3c). The model identified 106 compounds with a VIP score higher than 1 (Supplementary File 2, Table S7) and the top 30 were reported in Fig. 3c. Among them, metabolites such as xanthine, 2-hydroxyglutaric acid, hypoxanthine, serine, methionine sulfoxide, and asparagine, among others, were characterized by the highest VIP scores (Fig. 3c).

DSPC is a machine-learning algorithm that discovers the connections between many metabolites derived from few samples [37]. Considering that the low number of samples could be a limitation to the significance of our analysis, we used the DSPC to produce an additional validation of our results. Figure 3d shows the graphical representation of the DSPC results applied to the metabolite intensities obtained from control and treated larvae. Nodes correspond to the metabolites, and the edges represent the correlations among them. Red edges indicate positive correlations, and blue edges are negative correlations. Each node representing a metabolite is defined by its degree and betweenness values (Table 3) [37].

Table 3 DSPC network analysis.

The degree indicates the number of connections that a node has with other nodes, while betweenness measures the number of interconnections. Nodes with high degree and betweenness values are likely to be significant hubs [38]. We used a degree threshold greater than 5 and betweenness greater than 35 to identify metabolites characteristic of the lethal phenotype. Network analysis of control and treated larvae reveals that metabolites primarily involved in amino acid, polyamine, organic acid, and sugar metabolism, such as N-acetyl-D-hexosamine, putrescine, serine, inositol, homoserine, and malic acid, among others, play a central role in the mode of action of EOs (Fig. 3c and Table 3). Moreover, the results highlighted that: i) N-acethyl-D-hexosamine was positively correlated with serine, glucose-6-phosphate, cadaverine and malonic acid; ii) putrescine was positively correlated with glucose-6-phosphate, malonic acid and glycine, whereas iii) serine was negatively correlated with glycine, malonic acid and glucose-6-phosphate, and positively correlated with 3-phosphoglycerate, xylulose, homoserine and N-acetyl-hexosamine (Fig. 3d).

After multivariate and DSPC analysis the annotated metabolites were further analyzed through univariate analysis to highlight all the differentially accumulated metabolites between control and treated larvae (Supplementary File 1 Table S7 and Fig. 4). The t-test univariate analysis revealed that the treatment significantly impacted 137 out of 172 metabolites. Specifically, 56 metabolites showed significant accumulation in treated larvae, while 81 were significantly reduced (Supplementary File 2, Table S7). Further analysis was conducted using Fold Change (FC) with a cutoff of 1.5 (Supplementary File 2, Table S7) to focus on the most strongly affected metabolites (Supplementary File 2, Table S7). These results were then integrated using a Volcano plot analysis, applying a t-test p-value of ≤ 0.05 and an FC > 1.5, as depicted in Fig. 4 and detailed in Supplementary File 1, Table S5. The volcano plot allowed the reduction of the number of affected metabolites to 87, of which 42 were significantly reduced and 45 significantly increased (Fig. 4 and Supplementary File 1, Table S5).

Fig. 4
figure 4

Important features selected by volcano plot with fold change threshold > 1.5 and t-tests threshold ≤ 0.05. The red and violet circles represent features above the threshold. Note both fold changes and P values are Log10 transformed. The further its position away from the (0), the more significant the feature is N = 5

Among the analyzed compounds, there was a significant accumulation of polyamine spermidine, purines xanthine and hypoxanthine, gamma-aminobutyric acid (GABA), etc. In contrast, the levels of certain compounds, such as the amino acids asparagine and serine, and the organic acid glucaric acid, were significantly reduced in response to the treatment (Fig. 4).

Finally, the data were analyzed through pathway analysis to highlight which pathways were significantly and highly impacted by the EO treatment, considering our metabolomic coverage. The results highlighted that 32 pathways were significantly affected in response to EO treatment (Supplementary File 2, Table S7), but only 21 were characterized by an impact higher than 0.2 (Supplementary File 1, Table S6). Among them, the pathway related to the phenylalanine tyrosine and tryptophan biosynthesis was the most affected highlighting an impact of 1. It was followed by several pathways involved in amino acid biosynthesis (i.e., alanine aspartate and glutamate metabolism, glycine serine and threonine metabolism, arginine and proline metabolism, among others) and sugars metabolism (i.e. sucrose metabolism, fructose and mannose metabolism, glycerolipids metabolism, etc.) (Supplementary File 1, Table S6) (Fig. 5).

Fig. 5
figure 5

Here are the first four most affected pathways identified in the pathway analysis (Table 3), along with the full list of associated metabolites. Metabolites that belong to these pathways but were not identified during the analysis are highlighted in light blue. The colored boxes, ranging from light yellow to red, represent the statistical significance of the identified metabolites (light yellow indicates a P value closer to 0.05, while red indicates a P value greater than 0.001). Box plots show the trend of each metabolite identified as statistically significant by the t-test, with red boxes representing control larvae and green boxes representing treated larvae. Each code within the boxes corresponds to the KEGG code of the metabolites associated with the pathways; a Phenylalanine tyrosine and tryptophan biosynthesis (C00079—L-Phenylalanine, C00082—L-Tyrosine); b Alanine aspartate and glutamate metabolism (C00025—Glutamic acid, C00026—alpha-Ketoglutaric acid, C00042—Succinic acid, C00049—Aspartic acid, C00064—L-Glutamine, C00122—Fumaric acid, C00152—L-Asparagine, C00334—GABA), c Glycine serine and threonine metabolism (C00037—Glycine, C00065—Serine, C00097—L-Cysteine, C00188—Threonine, C00258—Glycerate), d sucrose metabolism (C00031—D-Glucose, C00085—D-Fructose 6-phosphate, C00092—D-Glucose 6-phosphate, C00095—D-Fructose, C00089—Sucrose, C00208—Maltose)

This research presents a comprehensive study examining the metabolic impact of C. myrrha EO treatment on Ae. aegypti larvae through GC–MS-driven untargeted metabolomic analysis. The analysis suggested that the EO triggered a broad spectrum of metabolic responses. In detail, one of the most impacted metabolisms was that of amino acids and significant changes were observed in pathways related to alanine, aspartate, and glutamate, as well as glycine, serine, and threonine metabolism. A similar metabolic response was found in Tribolium castaneum (Herbst) larvae and Drosophila melanogaster (Meigen) [39] adults after the treatment with organophosphorus pesticides and pyrethroids, respectively. The increase in amino acids suggested protein degradation since, as also reported in our work, an increase in free N-acetylamino acids that are only produced post-translationally by protein N-acetylation was observed [39]. Moreover, in our study, it was observed a decrease in tryptophan, a pivotal molecule involved in protein biosynthesis and whose down-accumulation has been observed in response to several insecticide treatments [39, 40]. In addition, Brinzer et al. [39] further demonstrated that tryptophan catabolism, one of the most impacted pathways in our experiment, is crucial in the defense of the organism against insecticides [39]. The degradation of the above-mentioned amino acid usually leads to an accumulation of neurotoxic compounds [39, 41], such as 3-hydroxykynurenine, which has also been observed in our study after the EO treatment. The reduction of fumaric acid and phenylalanine observed in this study is consistent with what was previously observed by Gao et al. [40]. Indeed, they detected a reduction of these metabolites in the moth Spodoptera frugiperda (JE Smith) exposed to the LD90 of the insecticide spinetoram, and they suggested that the downregulation of phenylalanine may reduce fumaric acid levels, slowing the tricarboxylic acid (TCA) cycle and decreasing guanosine triphosphate production under spinetoram-induced stress.

Besides the changes observed in phenylalanine, tyrosine, and tryptophan, which are end products of glycolysis and aromatic amino acids, in treated larvae it was also observed a general reduction in glycine, serine and threonine content whose metabolism is linked to glucose, glycogen, and pyruvate metabolism, all of which are integral to energy metabolism [41,42,43,44]. The potential alteration of energetic metabolism was confirmed by the impact on sucrose metabolism, the pentose phosphate pathway, and the TCA cycle. Their downregulation could be confirmed by the reduction in glycolytic phosphorylated sugars (i.e. glucose-6-phosphate, fructose-6-phosphate), an accumulation of those belonging to the pentose phosphate pathway (i.e. ribulose-5-phosphate), and the activation of purine metabolism.

The latter has also been observed in An. sinensis Wiedemann larvae in response to the treatment with deltamethrin [42] and has been reported to generate oxygen species (ROS), which could result in DNA damage and apoptosis in the affected individuals [42].

Insecticides, particularly neurotoxic compounds like permethrin, have been shown to disrupt normal physiological processes in Anopheles larvae, resulting in oxidative stress characterized by increased ROS levels. This oxidative stress can lead to cellular damage and, ultimately, death of the larvae [63, 64]. The accumulation of ROS is a well-documented response to various environmental stresses, including exposure to toxic compounds, and plays a critical role in the pathophysiology of insecticide-induced mortality [45, 46]. Earlier research demonstrated that the levels of GABA and polyamines can increase in response to oxidative stress also induced by ROS [47,48,49,50]. The relationship between insecticides, ROS accumulation, and the protective roles of osmoprotective compounds like GABA and polyamines, has been investigated by examining the transcriptomic responses of Anopheles larvae to insecticide exposure. RNA sequencing analyses have revealed significant changes in gene expression related to stress response, detoxification, and metabolic processes, indicating that larvae are actively responding to the oxidative stress induced by insecticides [45, 46]. This adaptive response may involve the upregulation of genes associated with the synthesis of osmoprotective compounds, thereby enhancing the ability of larvae to cope with the detrimental effects of ROS.

2.6 Non-target toxicity

Daphnia magna is a microcrustacean employed as a model organism for acute and chronic toxicity evaluation of compounds in aquatic ecosystems. Its large employment is due to its high sensitivity to toxic agents [51, 52]. Table 4 reports the toxicity of C. myrrha EO, which resulted toxic to D. magna with a LC50 of 4.51 µL/L, and a LC90 of 13.09 µL/L.

Table 4 Effects of Commiphora myrrha essential oil (EO) on Daphnia magna

The assessment of non-target toxicity of insecticides is of crucial importance for their real-world application. Herein, although the observed toxicity resulted marked, it is quite lower than that of conventional insecticides. For instance, pyrethroids are encompassed with a high toxicity on many non-target organisms. Indeed, the LC50 on some fish species at 48 h ranged around 1.6–5.13 µg/L for deltamethrin [53] and 0.05–245.7 µg/L for permethrin [54]. Regarding D. magna, the 48 h effective concentrations (EC50) are 0.16 µg/L for deltamethrin [55] and 0.2–0.6 µg/L for permethrin [56]. Furthermore, some natural products commercially employed as insecticides showed toxicity on this non-target species. For instance, the toxic effect of neem oil has been assessed on D. magna and the EC50 (48 h) value was 0.17 mL/L [57].

The present laboratory evaluation of C. myrrha EO toxicity on D. magna represents a preliminary step and, since insecticides are commonly employed in formulations, further studies are needed to potentially lower C. myrrha EO toxicity, for instance through its encapsulation.

2.7 Cytotoxicity

The cytotoxicity of C. myrrha EO was assessed on the HEK293 cell line, as reported in Table 5.

Table 5 Cytotoxic activity of Commiphora myrrha essential oil (EO) on human embryonic kidney cell line (HEK293)

The cytotoxicity of this EO has already been reported on squamous cell carcinoma (A431) (IC50 of 6.4 μg/mL) and on melanoma cells (RPMI-7951 and SK-MEL-28) (IC50 of 6.3 and 9.5 μg/mL, respectively). This cytotoxicity was also demonstrated on human keratinocytes (MBU-IM), with a major selectivity for tumor cell lines [58]. This cytotoxicity is undoubtedly linked to the presence of furanosesquiterpenes. Indeed, furanoeudesma-1,3-diene resulted to be cytotoxic in epidermoid carcinoma (A431) (IC50 of 9.9 μg/mL) and in malignant melanoma (RPMI-7951 e SK-MEL-28) (IC50 of 7.1 and 12.0 μg/mL, respectively) cell lines [58].

Regarding the cytotoxicity of isofuranodiene, this has been previously reported on different tumor lines such as cervical cancer (HeLa) (IC50 of 0.6 μg/mL), laryngeal cancer (Hep-2) (IC50 of 1.7 μg/mL), fibrosarcoma (HT-1080) (IC50 of 2.2 μg/mL), as well as on the stomach cancer cell line (SGC-7901) (IC50 of 4.8 μg/mL) or lung (A549) (IC50 of 9.4 μg/mL) [59]. Curzerene is also known for its cytotoxicity on tumor cell lines as human breast adenocarcinoma cells (MDA-MB 231) (IC50 of 13.9 μg/mL), glioblastoma (T98G) (IC50 of 60.3 μg/mL), and colon carcinoma (HCT116) (IC50 of 33.3 μg/mL) [60,61,62]. Information on the mode of action is mainly reported for isofuranodiene and primarily concerns cancer cell lines. In fact, the compound appears to exert its cytotoxicity by induction of apoptosis, inhibition of cell proliferation, and induction of necrosis [63]. A similar mechanism of action has also been reported for curzerene [64]. In this context, the cytotoxicity of C. myrrha EO could potentially be further reduced by using formulations, as has been demonstrated with other EOs [65].

The observed toxicity of the EO to HEK293 cells raises important considerations regarding its potential impact on human health and environmental safety. HEK293 cells are commonly used as a model for assessing cytotoxicity due to their sensitivity and relevance to human biology [66]. The toxicity may suggest that certain components of the EO could interact with cellular pathways, leading to harmful effects at molecular or organ level. From a human health perspective, the toxicity observed in vitro indicates a need for further studies, such as dose–response assessments, to determine safe exposure levels. EOs often contain bioactive compounds, such as terpenes and phenols, which, while beneficial at low concentrations, may exert cytotoxic or even genotoxic effects at higher doses. Regarding environmental impact, the release of toxic substances into ecosystems could harm aquatic and terrestrial organisms. EOs are increasingly being used in biopesticides and cosmetics, and their environmental fate (e.g., biodegradability, bioaccumulation) should be evaluated. Components toxic to human cells might similarly affect non-target organisms, disrupting ecological balance.

3 Conclusions

In the complex scenario of mosquito management, the search for innovative products is crucial, and botanicals show a promising potential. Concerning C. myrrha, this study highlights the larvicidal potential of its EO on four mosquito species of public health relevance. Moreover, its fractionation allowed the identification of furanosesquiterpenes as the main responsible for the bioactivity. The low LC50 values obtained (ranging from 4.42 to 16.80 μg/mL) could pave the way for the potential exploitation of myrrh as an effective larvicidal agent and this could also be favored by the established large-scale production of oleo-gum resin for food, pharmaceuticals, cosmetics, and perfumery applications and by its relatively low price on the market. Further studies are needed to develop formulations based on this EO and to reduce its toxicity on non-target organisms as well as on human cells.

4 Materials and methods

4.1 Chemicals and reagents

The mix of C7–C40 and C10–C40 alkanes, the solvents employed for GC–MS and HPLC–DAD analysis, as well as those used for the fractionation of the EO were purchased from Merck (Milan, Italy). Deionized water (> 18 MΩ cm resistivity) was purified using a Milli-Q SP Reagent Water System (Millipore, Bedford, MA, USA). The EO was acquired from dōTERRA (Utah, Stati Uniti, L.60205991 v3, https://www.doterra.com). Thin layer chromatography (TLC) was performed using silica gel 60 F254 plates, which were also oxidized with cerium molybdate stain. Column chromatography was conducted using silica gel 60 (70–230 mesh and 200–400 mesh, Merck, Milan, Italy).

4.2 Chemicals instrumentation

1H- (500 MHz) and 13C-NMR (125 MHz) spectra were acquired with a Bruker Avance III 500 MHz (Billerika, MA). The chemical shifts for 1H- and 13C-NMR are expressed as δ [parts per million (ppm)] and coupling constants are given in hertz. Deuterated chloroform was purchased from Merck (Milan, Italy). The following abbreviations are employed to show the coupling in the spectra reported in the Supplementary File 1: s (singlet), d (doublet), dd (doublet of doublets), ddd (doublet of doublets of doublets), t (triplet), dt (doublet of triplets), q (quartet), m (multiplet). The MS spectra were acquired through an Agilent 8890 GC–MS, coupled to a single quadrupole mass spectrometer (5977B) purchased from Agilent (Santa Clara, California, USA) and equipped with an autosampler PAL RTC120 (CTC Analytics AG, Zwingen, Switzerland). The IR spectra (cm−1) were obtained using a Perkin-Elmer FT-IR Spectrum Two UATR spectrometer (Perkin Elmer, Inc., Waltham, MA, USA). Optical rotation power was recorded on a Yasco 2000 digital polarimeter operating at 20 °C.

4.3 GC–MS qualitative analysis of essential oil (EO)

The EO and its fractions were analyzed through the GC–MS reported in the previous section (Chemicals Instrumentation). The EO and its fractions were solubilized in diethyl ether (1:100). The separation, identification, and semi-quantification of their compounds were performed by using the same analytical conditions reported by Gugliuzzo et al. [67].

4.4 HPLC–DAD quantitative analysis

The EO quantitative analysis was performed employing an Agilent Technologies (Palo Alto, CA, USA) HP-1100 series, made of an autosampler and a binary solvent pump, with a DAD detector. The separation was achieved on a Kinetex© PFP 100A column (100 × 4.6 mm i.d., 2.6 μm) from Phenomenex (Torrance, CA). The analytical conditions followed those previously reported [66]. The calibration curves were constructed by injecting different dilutions prepared from the stock solutions of isofuranodiene, curzerene, and furanoeudesma-1,3-diene diluted in acetonitrile, as reported in Supplementary File 1. The analytical method was validated as reported in Supplementary File 1.

4.5 Essential oil (EO) fractionation and purification of furanosesquiterpenes

The EO was fractioned using gravity column chromatography on silica gel (100 g) using n-hexane as the mobile phase. The EO (2 g) was loaded into the column by dry charge on silica (1:2 w/w) after its solubilization in dichloromethane. This fractionation process led to the isolation of two main fractions: fraction 1 (0.2 g) and fraction 2 (1.1 g). The main furanosesquiterpenes were purified following a method previously published [68, 69] with minor modifications (Supplementary File 1).

4.6 Mosquitoes

All mosquito colonies were maintained in the insectary of the University of Camerino at 80 ± 5% relative humidity, and at 28 ± 2°C and photoperiod of 12:12 h light:dark (L:D). Adults of Ae. aegypti and Ae. albopictus were preserved with a 10% sucrose solution, while those of An. stephensi and An. gambiae with a 5% solution. Larvae were fed following protocols previously reported [70] in deionized water with 0.5% p/v of artificial sea salt.

4.7 Mosquito larvicidal assays

Larvicidal assays were performed following the World Health Organization (WHO) procedures [71], applying some modifications [72]. The EO and its two fractions were diluted in DMSO at a 1:10 ratio, while the pure compounds at a 1:20 ratio to allow their complete solubilization. The tested concentrations were 10–25 μg/mL for the EO, up to 100 μg/mL for fraction 1, 2–10 μg/mL for fraction 2, 2–6 μg/mL for furanoeudesma-1,3-diene, and 2–9 μg/mL for isofuranodiene and curzerene.

4.8 MTT cytotoxicity assay

The antiproliferative potential of the EO on the human embryonic kidney 293 cell line (HEK293) was evaluated through the MTT assay [3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazoliumbromide] as reported previously by Page et al. [73]. The cells were exposed to different concentrations of the EO (0.78–100 μg/mL) solubilized in EtOH. The anticancer drug cisplatin (Merck, Milan, Italy) (0.01–50 μg/mL) was used as the positive control. The experiments were performed in triplicate. Cytotoxicity is expressed as the concentration of EO inhibiting cell growth by 50% (IC50). The detailed procedures are reported in Supplementary File 1.

4.9 GC–MS-driven untargeted metabolomic analysis

Sample extraction and derivatization followed the methodology outlined by Misra et al. [74], using 50 mg of larvae ground in liquid nitrogen and spiked with ribitol (0.2 mg/mL) as an internal standard. The derivatized samples were then analyzed using a Gas Cromatographer (8890 GC System, Agilent, Agilent, Santa Clara, California, USA) coupled to a single quad Mass spectrometer (5977C GC/MSD, Agilent, Santa Clara, California, USA), using a CTC PAL autosampler (CTC Analytics AG Industriestrasse 20 CH-4222 Zwingen Switzerland). The GC was equipped with a 5MS column (30 m × 0.25 mm × 0.25 µm) and a 10 m precolumn. The instrument's temperatures, analytical settings, and the MS-DIAL analysis for baseline filtering, alignment, deconvolution, peak extraction, and annotation adhered to the protocols set by Misra et al. [75]. Quality control and monitoring of instrumental performance and retention index (RI) shifts were ensured by injecting blank solvents, qualitative controls (QC), and n-alkane standards (C10-C40, even-numbered) at regular intervals. Peak annotations were based on retention index (RI) and spectral similarity, using an in-house EI spectral library. These annotations were classified as level 2 and/or level 3 according to the criteria suggested by Sumner et al. [76].

4.10 Toxicity tests on Daphnia magna

The acute toxicity tests were carried out according to the guidelines of the Organization for Economic Cooperation and Development (OECD) [77], with some modifications. 20 neonate D. magna adults (coming from an established laboratory colony, > 20 generations, CRI, Czech Republic) were treated in each test vessel, and four replicates were performed for a total of 80 microcrustaceans per treatment group. D. magna adults were placed in 250 mL of pure water, the EO diluted in Tween 80 (Sigma Aldrich, Czech Republic) or the control (only Tween 80) were then emulsified into the water at concentrations ranging from 1 to 15 µL/L. D. magna mortality was evaluated using a stereomicroscope after 48 h from the treatment. The conditions for the assays were pH ranging from 7.2 to 7.6; 25 ± 1 °C; electrical conductivity around 160 μS/cm; dissolved oxygen above 3 mg/L and total hardness of 40–48 mg CaCO3/L.

4.11 Statistical analysis

In mosquito toxicity tests, to quantify the toxicity of the different products, probit analysis was performed using the percentage of dead individuals after 24 h. The exposure concentrations (μg/mL) were log10 transformed, and the proportion of dead mosquitoes was used to calculate the median lethal concentration (LC50) and the lethal concentration required to kill 10, 30, and 90% of the individuals (LC10, LC30, and LC90, respectively). Probit analyses were carried out with the “ecotox” R package [78] to estimate the LC10, LC30, LC50, and LC90 with the associated 95% confidence interval (CI) and Chi-squares. For each species, a Generalized Linear Mixed Model (GLMM) was fit to test the efficacy of products and different concentrations. As predictor variables, we used the percentage of mortality in terms of the number of dead mosquitoes on total samples, resulting in “1” when dead, and “0” for alive. A binomial distribution with replicate membership as a random effect was employed. Post hoc analysis was then performed using estimated marginal means with the Bonferroni correction to test which factors of the model—i.e., products and concentrations—had a significant effect on the dependent variable out and to examine the statistical differences between treatments and doses on the four species. Statistical analyses were carried out in R 4.3.1. [79]. In non-target experiments, D. magna mortality was adjusted with Abbott’s formula [80]. Then, LC50 and LC90 values and the associated 95% CI for each tested product were calculated using probit analysis [81] through the Biostat 5.9.8 software.

The metabolomic experiments were done in a completely randomized design with five replications. Before multivariate and univariate analysis, the MS-DIAL Extracted intensities were normalized on the internal standard (ribitol), log10 transformed, and Pareto scaled using the open-source software metaboanalyst 6.0 [82]. After data normalization, the multivariate unsupervised Principal component analysis (PCA) and the supervised orthogonal partial least-squares-discriminant analysis (OPLS-DA) were conducted to observe and visualize the metabolic changes across the different experimental groups. The Hotelling’s T2 region, represented as an ellipse in the model's score plots, defines the 95% confidence interval for the modeled variation. The Variable Importance in Projection (VIP) scores each variable's overall contribution to the OPLS-DA model, with variables having VIP scores greater than 1 deemed significant for group differentiation. To prevent overfitting, the OPLS-DA model was validated through a permutation test (using a permutation number equal to 20), considering the model valid if the empirical p-values for Q2 and R2Y were ≤ 0.05 and if Q2 and R2Y values were close to 1. Pairwise partial correlations between metabolites were computed using Debiased Sparse Partial Correlation (DSPC), with a degree cut-off equal to 2, to assess the relationship between two metabolites while controlling for the influence of all other related metabolites [83]. Successively, the data were analyzed through univariate analysis using the Student’s t-test (P ≤ 0.05), in which the P value was corrected by the False Discovery Rate (FDR ≤ 0.05), and the Fold Change analysis (FC), using an FC value of 1.5. Data were then graphically reported using a Volcano plot (corrected P value ≤ 0.05 and FC > 1.5). Data were finally analyzed through the enrichment and pathway analysis using the Ae. aegypti KEGG database. Concerning the cytotoxicity assay, the IC50 values were determined with GraphPad Prism 5 (San Diego, CA, USA) computer program.